Neural crest cells are specialized multipotent embryonic stem cells found exclusively in vertebrates [1, 2, 3] . During embryonic development, these cells arise from the dorsal neural tube, undergo epithelial to mesenchymal transition, and subsequently migrate along stereotyped pathways to reach specific tissue targets, where they differentiate into a wide variety of cell types, such as glia and neurons of the peripheral nervous system, melanocytes, smooth muscle cells, craniofacial cartilage and bone tissues, or chromaffin cells of the adrenal medulla. In the trunk region, the ventrally migrating neural crest cells move through the somitic mesenchyme in a segmented pattern, presumably setting the basis for the metameric organization of sensory and sympathetic ganglia along the anterior-posterior axis later in development [4] . Early grafting experiments have shown that this highly specific migration behavior is primarily controlled by the microenvironment provided by the surrounding mesenchymal cells and their extracellular matrix. Different nonpermissive tissues forming barriers to neural crest cell movement have been identified, including the posterior sclerotome [5] , the perinotochordal region [6] , and transiently, the tissue underneath the dorsolateral ectoderm [7] . These boundaries contain, like the pathway tissues, migration-promoting proteins, such as fibronectin and laminins, but additionally include various cell surface and extracellular matrix components that may inhibit neural crest cell adhesion and invasion and, hence, maintain the moving cells within their trajectory. Among the candidate inhibitors are chondroitin 6-sulphate proteoglycans (CSPGs), peanut agglutinin (PNA)-binding glycoproteins [8] , F-spondin [9] , Tcadherin [10] , secreted class 3 semaphorins [11, 12] , and ephrins [13, 14] . Although they are selectively expressed in barrier tissues during the phase of neural crest cell migration, evidence for their direct involvement in the guiding process are only now emerging. The current findings suggest that the guidance of neural crest cell migration is not controlled by a single inhibitor, but rather depends on the concerted action of multiple factors that may jointly regulate different aspects of neural crest migration.
Our laboratory previously contributed to the identification of such candidate inhibitors by showing that most of the chondroitin-6-sulfate immunoreactivity and possibly also the PNA-binding carbohydrates are in barrier tissues of chick embryos linked to the presence of the large V0 and V1 splice-variants of the CSPG versican [15] . We then demonstrated that the versican expression closely correlates with the formation of nonpermissive extracellular matrices within the caudal sclerotome, the early subectodermal tissue, and to a lesser extent, around the notochord, where another member of the hyalectan family, aggrecan, may be the predominant CSPG [16] .
In extension of this study, we recently published in The Journal of Biological Chemistry new data that provide clear evidence for an active involvement of versican V0 and V1 in the guidance process [17] . Using stripe choice assays, we demonstrated that isolated versicans strongly inhibit the migration of Sox10/p75NTR double-positive neural crest stem cells on fibronectin by interfering with cell-substrate adhesion. We also showed that this inhibition is largely core glycoprotein dependent, as the complete removal of the glycosaminoglycan chains had only a minor effect on the inhibitory capacity.
Perris et al. showed that surface-bound aggrecan or versican alone are not supportive for neural crest cell migration [18] . Our data now expand this finding to demonstrate that intact versican isoforms V0 and V1 are not simply nonpermissive substrates, but actively override the adhesion-and migration-promoting capacity of fibronectin, which has been coated together with versicans in all of our experiments. Interestingly, we noted an inhibitory activity already at very low coating concentrations (less than 25 μg/ml), while Perris et al. reported that versican added to the cell culture medium in solution displayed, in contrast to aggrecan, no such effect even at very high concentrations of up to 3 mg/ml. This discrepancy either indicates that the large versican isoforms exert their inhibitory activity only after immobilization in a fibronectin-containing extracellular matrix, or may be linked to a partial degradation of the versican preparations used in their experiments. Similarly, this might explain why Perissinotto et al. [19] did not observe an inhibitory effect in a study implanting filters soaked in versican solutions into chick embryos, leading them to propose rather a "haptotactic-like" substrate function for versicans during the migration of neural crest cells (a notion that we could not confirm). A direct comparison of the versican concentrations effective in our assays with the amounts ultimately deposited in their experiments is difficult because of differences between coating and binding of versicans to the filter material they used for implantation (Nuclepore).
Since no cell surface receptors for versicans are currently known, the exact mechanism by which versicans V0/V1 may negatively control neural crest cells migration remains still elusive, but is likely to be directly or indirectly connected to the function of integrins and to Rho/Rac-mediated reorganization of the cytoskeleton [20] . It seems possible that versican cooperates with other known inhibitors belonging to the ephrin or the semaphorin families. Eph receptors expressed by migrating neural crest cells and ephrins present in barrier tissues are believed to participate in the induction of the repulsive response. This notion is mainly based on in vitro experiments with isolated neural crest cells and with chick trunk explant cultures [13] . No defects in the metameric patterning of neural crest cells migration have been observed in ephrin or Eph receptor knockout mice, however [21, 22, 23] . Similarly, neural crest cells avoid semaphorin 3A [11] and semaphorin 3F [12] in vitro. While the knockout of Sema 3A does not result in alterations of the neural crest cell migration [24] , inactivation of the genes encoding either semaphorin 3F or its receptor, neuropilin-2, leads to the disruption of the segmental migration pattern through the somites of mutant mice [12] . Nevertheless, the metameric pattern of the sensory dorsal root ganglia is not perturbed, again suggesting a more complex regulatory process.
The recent studies from our and other laboratories have just begun to unravel the molecular mechanism behind the control of neural crest cell migration. At present, many important questions that could explain their specialized moving behavior in vivo remain open, for example: (1) What are the relative contributions of the different factors in the guidance of neural crest cells? (2) What are the pathways that transduce the inhibitory signal within the cell? (3) Are neural crest cells responding all in the same way to a single inhibitor or are discrete subpopulations reacting differentially to distinct extracellular cues? The analysis of mouse models with multiple gene knockouts generated by combining conditional and constitutive gene inactivation approaches and the application of novel time-lapse imaging techniques in explant cultures or directly in vivo may help to answer these questions in the future.
